High-dose indomethacin for patent ductus arteriosus closure: how strong is the evidence?
作者信息
Manzar Shabih
出版信息
Pediatrics. 2006 May;117(5):1863; author reply 1863-4. doi: 10.1542/peds.2005-3087.
PMID:16651359
Abstract
摘要
相似文献
1
High-dose indomethacin for patent ductus arteriosus closure: how strong is the evidence?
Pediatrics. 2006 May;117(5):1863; author reply 1863-4. doi: 10.1542/peds.2005-3087.
2
Treatment of the patent ductus arteriosus: when, how, and for how long?
J Pediatr. 2009 Dec;155(6):774-6. doi: 10.1016/j.jpeds.2009.07.053.
3
Ibuprofen versus indomethacin for closure of patent ductus arteriosus.
N Engl J Med. 2001 Feb 8;344(6):457-8. doi: 10.1056/NEJM200102083440612.
4
[Drug therapy of patent ductus arteriosus in premature and newborn infants].
Kinderarztl Prax. 1978 Dec;46(12):644-8.
5
Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
Pediatrics. 2005 Dec;116(6):1361-6. doi: 10.1542/peds.2005-0293.
6
[An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
Bol Med Hosp Infant Mex. 1982 Aug;39(8):570-5.
7
Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates.
J Perinatol. 2011 Jan;31(1):21-4. doi: 10.1038/jp.2010.62. Epub 2010 May 27.
8
[Indomethacin for closure of persisting ductus arteriosus in the premature infant].
Monatsschr Kinderheilkd. 1981 Feb;129(2):118-20.
9
Criteria for use of indomethacin injection in neonates.
Clin Pharm. 1993 Mar;12(3):232-4.
10
Indomethacin for closure of patent ductus arteriosus in preterm neonates.
Indian J Pediatr. 1986 Jul-Aug;53(4):499-503.
Zotero 插件